Achyranthes root,
does it really help with Joints?
research showsJoint claims for Achyranthes root have extensive East Asian traditional use and many preclinical anti-inflammatory and cartilage-protective studies, but public web searches did not reliably verify direct human RCTs of a single Achyranthes ingredient on knee pain, WOMAC, or similar endpoints. Because human efficacy evidence is effectively not secured, the judgment is deferred.
ads claimAdvertisements mention 'joints,' 'cartilage,' 'combined with Boswellia,' and 'Achyranthes-containing complexes.' Direct human evidence for single-ingredient Achyranthes needs to be separated from evidence on combination products.
Useful facts when choosing a product
- Achyranthes differs substantially by species and plant part, including Achyranthes japonica and A. bidentata.
- Combination-ingredient studies were not transferred unchanged to the judgment for single-ingredient Achyranthes.
- Safety confirmation is needed in pregnancy/lactation, anticoagulant co-use, and kidney disease.
- This is a reassessment target if original human RCTs are obtained.
What the research actually shows
Preclinical studies on Achyranthes japonica/bidentata address inflammation, MMP, and chondrocyte markers. However, verification of original public RCTs showing that consumer Achyranthes extract alone improves knee pain, function, or structural change was insufficient. Therefore, this is left as judgment deferred rather than D, but the grade is not raised until additional human evidence is verified.
Why this is classified as ?
Because the existence and content of direct human efficacy evidence could not be verified, the judgment is ? / Judgment deferred.
Counterpoint. If Korean individually recognized ingredient dossiers or original papers are obtained, species, extract, and whether it is a combination product should be separated for reassessment.
Rejudgment record. Draft — Because the existence and content of direct human efficacy evidence could not be verified, the judgment is ? / Judgment deferred.
Cross-check — Codex and Claude
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Study 1 | Literature verification | Direct RCTs on joint pain and function | No direct RCT with verifiable author, sample, primary endpoint, and effect size was secured. | Core | ||
| Study 2 | Cell and animal studies | Mixed | Inflammation and cartilage surrogate markers | Mechanistic signals exist, but they are not evidence for human efficacy. | Background |
Receipt — 2 References
Every cited source was opened and checked against the live page on 2026-07-10.
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-10 · Corrections: none
Cite this verdict
[Chamgap] Achyranthes Root × Joints — Evidence Grade ?. 2 cited sources checked. Source: https://health-receipt.pages.dev/en/verdicts/joint-bone/achyranthes-joint/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.